FDA Approves Oravig (miconazole) Buccal Tablets for Treatment of Oropharyngeal Candidiasis
Links shared publicly online about this topic.
- 1,231total visits
FDA Approves Oravig (miconazole) Buccal Tablets for Treatment of Oropharyngeal Candidiasis
View full resource at drugs.com
Tags: Yeast Infection, Candidiasis, Vaginal Infection, FDA
Most Recently Shared on April 18, 2010 at 10:24 pm By:
FDA Approves Oravig (miconazole) Buccal Tablets for Treatment of Oropharyngeal Candidiasis - http://bit.ly/8Ze2GO
Oravig buccal tablets approved for oropharyngeal candidiasis - ONA
oncologynurseadvisor.com — “The FDA has approved Oravig (miconazole buccal tablets, from Strativa) for the treatment of oropharyngeal candidiasis (OPC) in patients 16 years of age.” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 19, 2010 at 2:54 pm By:
OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education
Oravig buccal tablets approved for oropharyngeal candidiasis http://goo.gl/fb/6pGLC
FDA Approves Oravig(TM) (miconazole) Buccal Tablets For Treatment Of Oropharyngeal Candidiasis
medicalnewstoday.com — “Strativa Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved Oravig (miconazole) buccal tablets for the treatment of oropharyngeal candidiasis (OPC), more commo” View full resource at medicalnewstoday.com
Most Recently Shared on April 17, 2010 at 1:05 pm By:
MNT Ear, Nose Throat Health News
FDA Approves Oravig(TM) (miconazole) Buccal Tablets For Treatment Of Oropharyngeal Candidiasis http://mnt.to/3Bpp #entnews
Advertisement
